Procter & Gamble Health: The financial results for the period ended September 30, 2026
Procter & Gamble Health (PGHL) filed a disclosure titled "The financial results for the period ended September 30, 2026". The company is valued at about ₹9,413 crore.
What happened
Procter & Gamble Health (PGHL) filed a disclosure with the exchanges on 2 November 2026 at 02:45 PM titled "The financial results for the period ended September 30, 2026".
From the filing: "Procter & Gamble Health Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026."
Company snapshot
Procter & Gamble Health is a small-cap company in the Healthcare sector, with a market value of about ₹9,413 crore.
The stock last traded at ₹5,670.5, against a 52-week range of ₹4,707–₹6,975 (18.7% below the high).
Before this filing the shares had moved −0.5% over the month and −14.1% over three months. Average daily turnover over the last 20 sessions was about ₹5.37 crore.
Promoters held 51.82% at the end of Q1 FY27. Foreign institutions owned 6.33% and domestic institutions 12.44%.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 339 | 66.2 | 39.87 |
| Q2 FY26 | 325 | 88.5 | 53.34 |
| Q3 FY26 | 374 | 77.6 | 46.74 |
| Q4 FY26 | 370 | 94.6 | 56.99 |
| Q1 FY27 | 364 | 96.2 | 57.92 |
What history shows
BCEIE's records show 4 previous results filings from the company since May 2026.
After those filings, the stock gained 2.8% on average the next trading day and was down 0.1% on average after five days (4 filings with price data).
Across 300 similar disclosures by other Healthcare companies, shares moved +1.3% on average the next day and +1.9% over five days; 57% of them rose the next day.
Market-wide, 10,143 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 42% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 6 Aug 2026 | A press release dated August 06, 2026, titled "Press Release on the… | −5.0% | −8.4% |
| 6 Aug 2026 | , the financial results for the quarter ended June 30, 2026. | −5.0% | −8.4% |
| 26 May 2026 | Outcome Of The Board Meeting Held On May 26, 2026 | +10.5% | +8.1% |
| 26 May 2026 | Board Meeting Outcome for Outcome Of The Board Meeting Held On May… | +10.5% | +8.1% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 2 November 2026: Board meeting — Financial Results.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.